Pure Labels

WEED, Inc., (OTC Pink: BUDZ), is a public company focused on purchasing land and building Commercial Grade “Cultivation Centers” to consult, assist, manage & lease to Licensed Dispensary owners and organic grow operators on a contract basis, with a concentration on the legal and medical marijuana sector. The Company’s plan is to become a True “Seed-to-Sale” company providing infrastructure, financial solutions and real estate options in this new emerging market.

GW Pharmaceuticals was founded in 1998 and is listed on both the NASDAQ Global Market (GWPH) and AIM, a market of the London Stock Exchange. GW is licensed by the UK Home Office to work with a range of controlled drugs for medical research purposes. The Group’s lead programme is the development of a product portfolio of cannabinoid prescription medicines to meet patient needs in a wide range of therapeutic indications, including Sativex® Oromucosal Spray and Epidiolex® for childhood epilepsy.

Puget Technologies (OTCQB: PUGE) is a publicly traded company focused on investing in companies that stay ahead of the curve and offer innovative products. Cannabis Biotech, a wholly owned subsidiary of Puget Technologies, is forging new frontiers in cannabinoid research and distribution. As the world grows to accept cannabis-based medicines, we are poised to meet the demand. Its other subsidiary, B-29, is responsible for manufacturing naturally-infused energy drinks.